Dupont Capital Management’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,003
| Closed | -$158K | – | 935 |
|
|
2022
Q4 | $158K | Sell |
2,003
-4,511
| -69% | -$355K | 0.01% | 837 |
|
|
2022
Q3 | $482K | Sell |
6,514
-3,111
| -32% | -$230K | 0.03% | 654 |
|
|
2022
Q2 | $627K | Buy |
9,625
+4,591
| +91% | +$299K | 0.03% | 626 |
|
|
2022
Q1 | $318K | Sell |
5,034
-446
| -8% | -$28.2K | 0.01% | 908 |
|
|
2021
Q4 | $291K | Sell |
5,480
-6,738
| -55% | -$358K | 0.01% | 978 |
|
|
2021
Q3 | $862K | Sell |
12,218
-1,717
| -12% | -$121K | 0.03% | 649 |
|
|
2021
Q2 | $929K | Buy |
13,935
+10,276
| +281% | +$685K | 0.02% | 668 |
|
|
2021
Q1 | $406K | Buy |
3,659
+2,235
| +157% | +$248K | 0.01% | 1032 |
|
|
2020
Q4 | $169K | Buy |
1,424
+1,093
| +330% | +$130K | ﹤0.01% | 1162 |
|
|
2020
Q3 | $29K | Sell |
331
-21,993
| -99% | -$1.93M | ﹤0.01% | 1230 |
|
|
2020
Q2 | $2M | Sell |
22,324
-3,085
| -12% | -$276K | 0.04% | 314 |
|
|
2020
Q1 | $2.53M | Sell |
25,409
-14,128
| -36% | -$1.41M | 0.06% | 235 |
|
|
2019
Q4 | $4.54M | Buy |
39,537
+6,267
| +19% | +$720K | 0.1% | 166 |
|
|
2019
Q3 | $4.2M | Buy |
33,270
+9,720
| +41% | +$1.23M | 0.1% | 182 |
|
|
2019
Q2 | $2.83M | Sell |
23,550
-2,175
| -8% | -$262K | 0.06% | 288 |
|
|
2019
Q1 | $2.25M | Buy |
25,725
+2,925
| +13% | +$256K | 0.05% | 339 |
|
|
2018
Q4 | $2.28M | Sell |
22,800
-3,482
| -13% | -$348K | 0.06% | 321 |
|
|
2018
Q3 | $3.01M | Sell |
26,282
-14,071
| -35% | -$1.61M | 0.07% | 282 |
|
|
2018
Q2 | $3.62M | Buy |
40,353
+22,535
| +126% | +$2.02M | 0.09% | 212 |
|
|
2018
Q1 | $1.3M | Sell |
17,818
-7,639
| -30% | -$559K | 0.03% | 441 |
|
|
2017
Q4 | $1.48M | Buy |
+25,457
| New | +$1.48M | 0.03% | 430 |
|